Markus Schnare

Prof. Markus Schnare


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2010 in Journal of Inflammation
Verified
Journal Article
Open access
PDF file
ELErin I Lafferty
Erin I Lafferty
SQSalman Qureshi
Salman Qureshi
MSMarkus Schnare
Markus Schnare
By virtue of its direct contact with the environment, the lung is constantly challenged by infectious and non-infectious stimuli that necessitate a robust yet highly controlled host response coordinated by the innate and adaptive arms of the immune system. Mammalian Toll-like receptors (TLRs) function as crucial sentinels of microbial and non-infectious antigens throughout the respiratory tract and mediate host innate immunity. Selective induction of inflammatory responses to harmful environmental exposures and tolerance to innocuous antigens are required to maintain tissue homeostasis and integrity. Conversely, dysregulated innate immune responses manifest as sustained and self-perpetuating tissue damage rather than controlled tissue repair. In this article we review aspects of Toll-like receptor function that are relevant to the development of acute lung injury and chronic obstructive lung diseases as well as resistance to frequently associated microbial infections.

6 June 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
OPOlaf Pinkenburg
Olaf Pinkenburg
TMTorben Meyer
Torben Meyer
NBNorbert Bannert
Norbert Bannert
SNSteven Norley
Steven Norley
KBKathrin Bolte
Kathrin Bolte
MSMarkus Schnare
Markus Schnare
In addition to their well-known antibacterial activity some antimicrobial peptides and proteins (AMPs) display also antiviral effects. A 27 aa peptide from the N-terminal part of human bactericidal/permeability-increasing protein (BPI) previously shown to harbour antibacterial activity inhibits the infectivity of multiple Influenza A virus strains (H1N1, H3N2 and H5N1) the causing agent of the Influenza pneumonia. In contrast, the homologous murine BPI-peptide did not show activity against Influenza A virus. In addition human BPI-peptide inhibits the activation of immune cells mediated by Influenza A virus. By changing the human BPI-peptide to the sequence of the mouse homologous peptide the antiviral activity was completely abolished. Furthermore, the human BPI-peptide also inhibited the pathogenicity of the Vesicular Stomatitis Virus but failed to interfere with HIV and measles virus. Electron microscopy indicate that the human BPI-peptide interferes with the virus envelope and at high concentrations was able to destroy the particles completely.

1 January 2011
Verified
Book Chapter
Closed access
MSMarkus Schnare
Markus Schnare
SQSalman T Qureshi
Salman T Qureshi